Med Ed 101
JULY 7, 2024
JS is a 45 year-old male who has been taking bupropion SR 150 mg twice daily for about 4 weeks. He has been taking it for depression. He reports that depressive symptoms have started to improve but he does notice that he has a harder time getting to sleep and staying asleep since beginning the […] The post Wellbutrin XL Versus Bupropion SR – Insomnia Rates appeared first on Med Ed 101.
Express Pharma
JULY 7, 2024
Season 2 of the Express Pharma – Nutrify Today Boardroom series presents key dialogues from the Nutrify C Suite Sumflex 2024, held over June 6-7, 2024. In this video, industry leaders dissect the trends impacting the Vitamins, Minerals and Supplements (VMS) segment in India’s Pharma market, ranging from the focus shift from illness to wellness, emerging segments like sports nutrition, sleep products, increasing regulator oversight requiring evidence based nutraceuticals, and future innovat
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JULY 7, 2024
Novartis, Pfizer, Otsuka and Novo Nordisk have been called out for breaching the ABPI code of practice
Express Pharma
JULY 7, 2024
OnabotulinumtoxinA (BoNT-A) and monoclonal antibodies against the calcitonin gene-related protein (anti-CGRP mAbs) have emerged as the first disease-specific preventative treatments to be approved for chronic migraine. At the 10th Congress of the European Academy of Neurology (EAN) 2024, Danilo Antonio Montisano, MD, presented real-world evidence findings from a retrospective, observational multicenter cohort study (RAMO) comparing the effectiveness of anti-CGRP mAbs and BoNT-A for chronic migra
Speaker: Joe Sharpe and James Carlson
In the world of small business management, the challenge of managing payroll & HR efficiently while scaling operations can be overwhelming. Yet, with the right strategies in place, these challenges can become opportunities for growth and innovation. In this session, Joe Sharpe, Senior Director of Managed Payroll Services at IRIS, will reveal practical methods and expert insights for outsourcing and streamlining payroll processes, resulting in substantial time and resource savings.
FDA Law Blog: Biosimilars
JULY 7, 2024
By Gail H. Javitt — In its final rule on laboratory developed tests (LDTs) (see our prior blog here ), FDA acknowledged that “some laboratories may lack familiarity, experience, or existing infrastructure for complying with FDA requirements” and made multiple references to a “small entity compliance guidance” that the agency intended to publish to “provide additional guidance to small businesses.
Drug Patent Watch
JULY 7, 2024
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Drug Patent Watch
JULY 7, 2024
This chart shows the drugs with the most patents in France. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.
Pharmacy Joe
JULY 7, 2024
In this episode, I’ll discuss the suppression of antimicrobial susceptibility results. Episode 937: Is your micro lab hiding susceptibility data from you? Subscribe on iTunes , Android , or Stitcher When a hospital microbiology laboratory performs antimicrobial susceptibility testing using microdilution or disk diffusion methods, not all of the results are presented to clinicians in the medical record.
Expert insights. Personalized for you.
95 
Let's personalize your content